glp-1 injections gonzales GLP Weight Loss Medications GLP-1 Agonists: A Comprehensive Overview
Description
More than half of the participants receiving tirzepatide lost 25% or more of their body weight during the trial period
Nevertheless, there is scope for further investigation in the youngest children with obesity to optimise weight loss treatment regimens and minimise side effects, important factors to ensure adherence to medication
Holst, The expanding incretin universe: from basic biology to clinical translation
Potentially, but only under medical supervision
Consequently, only about 1020% of total plasma GLP-1 remains in its biologically active form, with the majority rapidly inactivated by DPP-IV [12]
